Deals in brief

Total medical devices industry deals for September 2019 worth $2.15bn were announced globally, according to GlobalData’s deals database.

The value marked a decrease of 18.5% over the previous month and a drop of 56% when compared with the last 12-month average of $4.89bn.

In terms of number of deals, the sector saw a rise of 4.1% over the last 12-month average with 127 deals against the average of 122 deals. In value terms, North America led the activity with deals worth $1.11bn.

Medical devices industry deals in September 2019: Top deals

The top five medical devices deals accounted for 68.9% of the overall value during September 2019.

The combined value of the top five medical devices deals stood at $1.48bn, against the overall value of $2.15bn recorded for the month.

The top five medical devices industry deals of September 2019 tracked by GlobalData were:

1) Stryker’s $500m acquisition of GYS Tech and Mobius Imaging

2) The $450m acquisition of EndoSpan by CryoLife

3) Cambridge Innovation Capital, Escala Capital Investments Cyprus, LGT Impact Ventures, Silk Road Fund and Watrium’s $242.67m venture financing of CMR Surgical

4) The $230m acquisition of Cheetah Medical by Baxter International

5) Aleph Venture Capital, Ansonia Holdings Singapore, Joy Capital and Samsung NEXT Ventures’ venture financing of Healthy io for $60m.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.

The US medical devices industry saw a drop of 19% in overall deal activity during September 2019, when compared with the last 12-month average, according to GlobalData’s deals database. A total of 64 deals worth $1.11bn were announced in September 2019, compared to the 12-month average of 79 deals. Venture financing was the leading category in the month in terms of volume with 45 deals which accounted for 70.3% of all deals. In second place was M&A with 17 deals, followed by private equity with two transactions, respectively accounting for 26.6% and 3.1% of overall deal activity in the country’s medical devices industry during the month.

Total medical devices industry M&A deals in September 2019 worth $1.26bn were announced globally, according to GlobalData’s deals database. The value marked a decrease of 31.8% over the previous month and a drop of 66.2% when compared with the last 12-month average, which stood at $3.72bn. North America held the top position in terms of volumen and value, with total announced deals in the period worth $768.94m. In 2019, as of the end of September 2019, medical devices M&A deals worth $31.59bn were announced globally, marking an increase of 39.8% year on year.

Dassault Systèmes has completed its acquisition of Medidata Solutions, which will now operate as a Dassault Systèmes brand. Dassault Systèmes acquired all of the issued and outstanding common shares of Medidata for $92.25 per share in cash, representing a total value of approximately $5.8bn. Medidata ceased trading on NASDAQ as of the close of trading on 28 October 2019.

Abbott has partnered with Omada Health to provide personalised, on-the-go digital care and coaching for type 2 diabetes patients. Abbott’s continuous glucose monitoring system FreeStyle Libre will be combined with Omada Health’s digital care platform to create an integrated solution delivering real-time glucose data and actionable information for diabetes management.

US-based conglomerate 3M has completed the acquisition of wound care solutions provider Acelity and its KCI subsidiaries globally for around $6.7bn. The deal is part of 3M’s strategy to boost presence in advanced and surgical wound care. Acelity is a medical technology firm that offers advanced wound care and speciality surgical solutions under the KCI brand.